Aurora Cannabis (ACB) vs Intercure (INCR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Aurora Cannabis (ACB) has outperformed Intercure (INCR) over the past year, losing 27.4% versus a loss of 37.5%. Over five years, INCR leads with a -85.8% price change compared with -93.7% for ACB. Aurora Cannabis is the larger company by market cap ($280.5 million vs $75.5 million), about 3.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | INCR |
|---|---|---|
| Share price | $4.43 | $5.03 |
| Market cap | $280.46M | $75.47M |
| 1-day change | -0.67% | -1.95% |
| YTD return | +4.98% | +10.55% |
| 1-year return | -27.38% | -37.52% |
| 5-year return | -93.70% | -85.81% |
| EPS (TTM) | $-0.61 | $-0.95 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $8.40 |
| 52-week low | $2.56 | $3.40 |
| Distance from 52-week high | -33.53% | -40.12% |
| Analyst consensus | buy | — |
| Average volume | 1.36M | 21.73K |
| Shares outstanding | 63.31M | 15.00M |
| Employees | 1,028 | 285 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Aurora Cannabis is about 3.7 times larger than Intercure by market value ($280.46M vs $75.47M).
- ACB has outperformed INCR by 10.1 percentage points over the past year.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,028 employees
About Intercure
INCR stock →InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Healthcare · Drug Manufacturers - Specialty & Generic · 285 employees
ACB vs INCR FAQ
Which is bigger, Aurora Cannabis or Intercure?
Aurora Cannabis (ACB) is larger, with a market capitalization of $280.46M compared with $75.47M for Intercure (INCR).
Which stock has performed better over the past year, ACB or INCR?
ACB returned -27.38% over the past 12 months, compared with -37.52% for INCR (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Intercure in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.